These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21968110)

  • 1. Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.
    Onojafe IF; Adams DR; Simeonov DR; Zhang J; Chan CC; Bernardini IM; Sergeev YV; Dolinska MB; Alur RP; Brilliant MH; Gahl WA; Brooks BP
    J Clin Invest; 2011 Oct; 121(10):3914-23. PubMed ID: 21968110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3.
    Onojafe IF; Megan LH; Melch MG; Aderemi JO; Alur RP; Abu-Asab MS; Chan CC; Bernardini IM; Albert JS; Cogliati T; Adams DR; Brooks BP
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4945-4952. PubMed ID: 30347088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informed reasoning: repositioning of nitisinone to treat oculocutaneous albinism.
    Manga P; Orlow SJ
    J Clin Invest; 2011 Oct; 121(10):3828-31. PubMed ID: 21968107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of SLC24A5 variants and evaluation of Nitisinone treatment efficacy in a zebrafish model of OCA6.
    Yousaf S; Sethna S; Chaudhary MA; Shaikh RS; Riazuddin S; Ahmed ZM
    Pigment Cell Melanoma Res; 2020 Jul; 33(4):556-565. PubMed ID: 32274888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
    Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
    J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
    Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-mediated tyrosinase gene transfer restores melanogenesis and retinal function in a model of oculo-cutaneous albinism type I (OCA1).
    Gargiulo A; Bonetti C; Montefusco S; Neglia S; Di Vicino U; Marrocco E; Corte MD; Domenici L; Auricchio A; Surace EM
    Mol Ther; 2009 Aug; 17(8):1347-54. PubMed ID: 19436266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron microscopic DOPA reaction test for oculocutaneous albinism.
    Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
    Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
    Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
    Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
    King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
    Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane transport proteins in melanosomes: Regulation of ions for pigmentation.
    Wiriyasermkul P; Moriyama S; Nagamori S
    Biochim Biophys Acta Biomembr; 2020 Dec; 1862(12):183318. PubMed ID: 32333855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional validation of the albinism-associated tyrosinase T373K SNP by CRISPR/Cas9-mediated homology-directed repair (HDR) in rabbits.
    Song Y; Zhang Y; Chen M; Deng J; Sui T; Lai L; Li Z
    EBioMedicine; 2018 Oct; 36():517-525. PubMed ID: 30274819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
    Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
    FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human oculocutaneous albinism. From clinical observation to molecular biology].
    Aquaron R
    Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.
    Newton JM; Cohen-Barak O; Hagiwara N; Gardner JM; Davisson MT; King RA; Brilliant MH
    Am J Hum Genet; 2001 Nov; 69(5):981-8. PubMed ID: 11574907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Basis of Chemical Chaperone Therapy for Oculocutaneous Albinism Type 1A.
    Teramae A; Kobayashi Y; Kunimoto H; Nakajima K; Suzuki T; Tsuruta D; Fukai K
    J Invest Dermatol; 2019 May; 139(5):1143-1149. PubMed ID: 30447237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oculocutaneous and ocular albinism].
    Kubasch AS; Meurer M
    Hautarzt; 2017 Nov; 68(11):867-875. PubMed ID: 29018889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of retinal pigment epithelium from patient iPSC line to model oculocutaneous albinism (OCA)1A disease.
    Subramani J; Patlolla N; Battu R; Saiyed T; Pal R
    J Biosci; 2024; 49():. PubMed ID: 38287676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.